We'll continue to adjust our staffing levels to the sales performance we have.

While our comparable-store sales were negative for the quarter, we are beginning to see improving sales trends in certain areas of our business, reflecting a better balance of fashion, brands and prices. We remain focused on addressing opportunities to increase volume.

We've wanted to be part of this community for more than 25 years, and we are excited to have the opportunity to quickly expand our presence in the greater Boston area.

Our business, like many others, has been impacted by the recent unprecedented events, which served to compound the softening of our business following July's anniversary sale.

Our September sales performance was softer than expected. However, when you consider our exceptional sales performance in July and August, lean inventories, and the competitive environment, we expected there would be some weakening in September sales.

Our performance continues to be driven by robust sales of our innovative oncology products which have helped nearly double our revenues in a three-year time period.